1. Infection

Infection

Infection is a pathophysiological process that involves the invasion and colonization of a living organism (host) by disease-causing infectious agents, the reaction of host tissues to these agents and the toxins they produce, and the transmission of infectious agents to other hosts. Common infectious agents include viruses, viroids, prions, bacteria, nematodes, arthropods, and other macroparasites such as tapeworms. Hosts can fight infections using their immune system. Mammals often engage both innate and adaptive immune systems to eliminate infectious agents or inhibit their growth and transmission. When infection occurs, anti-infective drugs can suppress the infection. Several broad types of anti-infective drugs exist, depending on the type of organism targeted; they include antibacterial (antibiotic), antiviral, antifungal and antiparasitic agents.

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-N14232
    Inactone 487-34-3
    Inactone is a bioactive molecule of 3-glutarimidyl group that inhibits large ribosomal subunit.
    Inactone
  • HY-N14233
    Inosamycin A 91421-97-5
    Inosamycin A is a broad-spectrum antimicrobial antibiotic.
    Inosamycin A
  • HY-N14234
    Isohematinic acid 86408-37-9
    Isohematinic acid has weak anti-anaerobic bacteria action.
    Isohematinic acid
  • HY-N14236
    Epopromycin B 153540-56-8
    Epopromycin B inhibits the cell wall synthesis of lettuce protoplasts, thereby exhibiting herbicidal activity. Epopromycin B exhibits cytotoxicity in B16 melanoma cell with an IC50 of 0.003 µg/mL.
    Epopromycin B
  • HY-N14237
    Epoxyquinomicin A 175448-31-4
    Epoxyquinomicin A is an antibiotic that can be isolated from Amycolatopsis sp. Epoxyquinomicin A exhibits inhibitory activity against Micrococcus luteus, Bacillus subtilis, Pasteurella piscicida and Staphylococcus aureus with a MIC of 3-12.5 µg/mL. Epoxyquinomicin A exhibits cytotoxicity in cancer cell L1210, B16 and S180 with IC50 of 2-8 µg/mL. Epoxyquinomicin A exhibits anti-inflammatory effects against collagen-induced arthritis.
    Epoxyquinomicin A
  • HY-N14238
    Epoxyquinomicin B 175448-32-5
    Epoxyquinomicin B is an antibiotic that can be isolated from Amycolatopsis sp. Epoxyquinomicin B exhibits inhibitory activity against Micrococcus luteus, Bacillus subtilis, Pasteurella piscicida and Staphylococcus aureus with a MIC of 6.25-12.5 µg/mL. Epoxyquinomicin B exhibits cytotoxicity in cancer cell L1210 with IC50 of 16.3 µg/mL. Epoxyquinomicin B exhibits anti-inflammatory effects against collagen-induced arthritis.
    Epoxyquinomicin B
  • HY-N14239
    Jietacin A 109766-61-2
    Jietacin A is found to be resistant to nematode, it can kill Burs helenchus Lignicolus with the concentration of 0.25 μg/mL.
    Jietacin A
  • HY-N14242
    Jietacin B 109766-62-3
    Jietacin B is found to be resistant to nematode, it can kill Burs helenchus Lignicolus with the concentration of 0.25 μg/mL.
    Jietacin B
  • HY-N14246
    Exfoliamycin 148084-37-1
    Exfoliamycin is a naphthoquinone antibiotic found by Streptomyces Exfoliamycin Tu 1424 and is active against Gram-positive bacteria.
    Exfoliamycin
  • HY-N14247
    Exfoliazone 132627-73-7
    Exfoliazone is a phenoxazine antibiotic. Exfoliazone has the activity of resisting Valsa ceratosperma, and the ED50 that inhibits mycelial growth is 70 μg/mL.
    Exfoliazone
  • HY-N14248
    Melithiazole A 170894-30-1
    Melithiazol A is an antibiotic. Melithiazole A is a β-methoxyacrylate (MOA) inhibitor with strong anti-agent activity. Antifungal and cytotoxic agent.
    Melithiazole A
  • HY-N14249
    Melithiazole B 170894-31-2
    Melithiazol B is an antibiotic. Melithiazole B is a β-methoxyacrylate (MOA) inhibitor with strong anti-agent activity. Antifungal and cytotoxic agent.
    Melithiazole B
  • HY-N14250
    Melithiazole C 214420-47-0
    Melithiazol C is an antibiotic. Melithiazole C is a β-methoxyacrylate (MOA) inhibitor with strong anti-agent activity. Antifungal agent.
    Melithiazole C
  • HY-N14251
    Melithiazole K 248938-47-8
    Melithiazol K is an antibiotic. Melithiazole K is a β-methoxyacrylate (MOA) inhibitor with strong anti-agent activity.
    Melithiazole K
  • HY-N14252
    Melithiazole N 248938-54-7
    Melithiazol N is an antibiotic. Melithiazole N is a β-methoxyacrylate (MOA) inhibitor with strong anti-agent activity.
    Melithiazole N
  • HY-N14254
    Hypelcin A-Ⅰ 93397-17-2
    Hypelcin A-I has anti-Gram-negative bacterial and fungal activity.
    Hypelcin A-Ⅰ
  • HY-N14256
    Amycin B 129313-99-1
    Amycin B, a natural Niphimycin analog, is active against Gram-positive bacteria and fungi.
    Amycin B
  • HY-N14258
    Kerriamycin A 98474-20-5
    Kerriamycin A has anti-Gram-positive bacterial effect and can inhibits Ai's ascites cancer.
    Kerriamycin A
  • HY-N14259
    Kerriamycin C 98495-38-6
    Kerriamycin C has anti-Gram-positive bacterial effect and can inhibits Ai's ascites cancer.
    Kerriamycin C
  • HY-N14260
    Hypelcin A-II 93397-16-1
    Hypelcin A-II has anti-Gram-negative bacterial and fungal activity.
    Hypelcin A-II
Cat. No. Product Name / Synonyms Application Reactivity